Gene clues may predict preeclampsia in egg donor pregnancies
NCT ID NCT07178652
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at how certain gene combinations (HLA-C and KIR) might affect the risk of preeclampsia in pregnancies from egg donation. Researchers will collect cheek swabs from mothers, children, and egg donors to analyze DNA. By comparing gene patterns between those who developed preeclampsia and those who did not, they hope to uncover immune-related risk factors. The goal is to improve screening and care for future pregnancies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help identify women at higher risk for preeclampsia after egg donation, leading to better monitoring and prevention strategies.
What could go wrong
This is an observational study, not a treatment trial. It will not directly prevent or cure preeclampsia, and results may not apply to all populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA (PE) RISK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.